GSK
GSK-Merck back new developing world cancer charity
September 14, 2011Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer
GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …
GSK-Amicus start late-stage trials of Fabry disease treatment
September 14, 2011Research and Development Amicus Therapeutics, Fabry disease, GSK
GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …
GSK scales back breast cancer trial
September 12, 2011Research and Development, Sales and Marketing GSK, Tyverb
GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …
Dendreon drops GSK as Provenge manufacturing partner
September 8, 2011Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news
Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
GSK Parkinson’s drug shows motor skills benefits
August 16, 2011Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news
GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …
GSK moves into diagnostics with Enigma
August 12, 2011Sales and Marketing Diagnostics, GSK, infectious diseases
GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …
Witty backs Britain as manufacturing, R&D location
July 29, 2011Manufacturing and Production, Research and Development GSK
GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …
GSK sales down on Avandia and pandemic products
July 27, 2011Research and Development, Sales and Marketing GSK
GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …
Augmentin recall expanded on contamination fears
July 26, 2011Manufacturing and Production, Sales and Marketing Augmentin, GSK, recalls
GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …
GSK downsizes Irish OTC plant
July 18, 2011Manufacturing and Production GSK, Ireland, pharma manufacturing news
GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …
GSK changes the way its US sales reps are assessed
July 6, 2011Sales and Marketing GSK, pharma sales force
GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …
GSK welcomes outside researchers to its ‘open lab’
June 29, 2011Research and Development GSK, TB, academic alliance, malaria, open lab
The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
GlaxoSmithKline fined $41m for manufacturing failings
June 28, 2011Manufacturing and Production GSK, pharma manufacturing news
GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …
NICE guideline helping to cut referrals
June 20, 2011GSK, NICE, bph
A NICE guideline on treating lower urinary tract symptoms (LUTS) in men is helping to cut referrals to urologists, thereby …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
